BrainsWay Ltd. announced an exclusive distribution agreement with Gaelan Medical Trade LLC. The agreement establishes a multiyear framework whereby BrainsWay will supply its patented, revolutionary Deep Transcranial Magnetic Stimulation (Deep TMS) system, which is currently marketed in various markets for brain disorders including major depressive disorder (MDD) and obsessive-compulsive disorder (OCD), to now be marketed and sold throughout the UAE. The agreement between BrainsWay and Gaelan, a member of the Dubai-based international conglomerate Ghassan Aboud Group, follows the recent historic diplomatic breakthrough in economic ties established with The Abraham Accords Declaration, which was recently signed between Israel, the UAE, and the United States.